Treatment of Postnasal Drip

First-Line Treatment Algorithm

The American Academy of Otolaryngology recommends starting with a first-generation antihistamine plus decongestant combination for a minimum of 3 weeks as the most effective first-line treatment for postnasal drip, regardless of whether the cause is allergic or non-allergic rhinitis 1, 2
The American College of Allergy, Asthma, and Immunology suggests beginning with first-generation antihistamine/decongestant combinations as the primary treatment for non-allergic rhinitis, with specific effective combinations including dexbrompheniramine maleate plus sustained-release pseudoephedrine sulfate and azatadine maleate plus sustained-release pseudoephedrine sulfate 1, 2, 3
The minimum treatment duration is 3 weeks for chronic cases, with most patients improving within days to 2 weeks of starting therapy 1, 2

The American Academy of Otolaryngology recommends starting with once-daily dosing at bedtime for the first few days to minimize sedation from first-generation antihistamines, increasing to twice-daily therapy after tolerance develops 1, 2

The American College of Chest Physicians suggests ipratropium bromide nasal spray as an effective alternative for patients who don't respond to antihistamine/decongestant combinations or have contraindications 1, 2
For chronic sinusitis with postnasal drip, a minimum of 3 weeks of antibiotics effective against H. influenzae, mouth anaerobes, and S. pneumoniae, combined with 3 weeks of oral antihistamine/decongestant and 5 days of nasal decongestant, followed by 3 months of intranasal corticosteroids, is recommended 1

The American College of Obstetricians and Gynecologists advises using caution with decongestants during the first trimester of pregnancy due to potential fetal heart rate changes 1
For chronic nasal polyps, short courses of oral corticosteroids followed by intranasal corticosteroids show significant improvement in postnasal drip symptoms, with prednisolone-treated groups showing significantly greater improvements in nasal symptoms at 2, 7, and 12 weeks compared to placebo 4

The American Academy of Allergy, Asthma, and Immunology recommends the combination of ipratropium bromide nasal spray and intranasal corticosteroid for treating rhinorrhea, as it is more effective than either drug alone without increased adverse events 5
The American Academy of Allergy, Asthma, and Immunology suggests that ipratropium bromide effectively reduces rhinorrhea through anticholinergic drying effects without systemic cardiovascular side effects, though it has no effect on other nasal symptoms 5
The American Academy of Allergy, Asthma, and Immunology advises to use oral and topical decongestants with caution in older adults, young children, and patients with cardiac arrhythmia, angina, cerebrovascular disease, hypertension, bladder neck obstruction, glaucoma, or hyperthyroidism 5

The American Academy of Allergy, Asthma, and Immunology considers short courses of oral corticosteroids (5-7 days) followed by intranasal corticosteroids, which show significant improvement in postnasal drip symptoms 5